Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chonglei Bi

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Biomed Research International|July 4, 2014
MicroRNA: important player in the pathobiology of multiple myelomaChonglei Bi, Wee Joo Chng
Oncotarget|August 18, 2016
PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylationPhaik Ju Teoh, Chonglei Bi, Chirackal Sintosebastian, et al.
Oncotarget|August 30, 2013
Clonogenic multiple myeloma cells have shared stemness signature associated with patient survivalRenji Reghunathan, Chonglei Bi, Shaw Cheng Liu, et al.
Oncotarget|July 13, 2015
Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myelomaChonglei Bi, Tae-Hoon Chung, Gaofeng Huang, et al.
Oncotarget|December 20, 2017
VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of BimNurulhuda Mustafa, Jeannie Xue Ting Lee, Huey Fang Adina Nee, et al.
Plos One|July 2, 2011
Determinants of sensitivity to DZNep induced apoptosis in multiple myeloma cellsZhigang Xie, Chonglei Bi, Lip Lee Cheong, et al.
Blood|July 8, 2011
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AMLJianbiao Zhou, Chonglei Bi, Lip-Lee Cheong, et al.
Molecular Cancer|September 22, 2012
The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemiaJianbiao Zhou, Lip-Lee Cheong, Shaw-Cheng Liu, et al.
Molecular Oncology|April 12, 2017
Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinomaLi R Kong, Tuan Z Tan, Weijie R Ong, et al.
Blood|September 17, 2011
Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaSiok-Bian Ng, Junli Yan, Gaofeng Huang, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Biomed Research International|July 4, 2014
MicroRNA: important player in the pathobiology of multiple myelomaChonglei Bi, Wee Joo Chng
Oncotarget|August 18, 2016
PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylationPhaik Ju Teoh, Chonglei Bi, Chirackal Sintosebastian, et al.
Oncotarget|August 30, 2013
Clonogenic multiple myeloma cells have shared stemness signature associated with patient survivalRenji Reghunathan, Chonglei Bi, Shaw Cheng Liu, et al.
Oncotarget|July 13, 2015
Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myelomaChonglei Bi, Tae-Hoon Chung, Gaofeng Huang, et al.
Oncotarget|December 20, 2017
VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of BimNurulhuda Mustafa, Jeannie Xue Ting Lee, Huey Fang Adina Nee, et al.
Plos One|July 2, 2011
Determinants of sensitivity to DZNep induced apoptosis in multiple myeloma cellsZhigang Xie, Chonglei Bi, Lip Lee Cheong, et al.
Blood|July 8, 2011
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AMLJianbiao Zhou, Chonglei Bi, Lip-Lee Cheong, et al.
Molecular Cancer|September 22, 2012
The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemiaJianbiao Zhou, Lip-Lee Cheong, Shaw-Cheng Liu, et al.
Molecular Oncology|April 12, 2017
Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinomaLi R Kong, Tuan Z Tan, Weijie R Ong, et al.
Blood|September 17, 2011
Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaSiok-Bian Ng, Junli Yan, Gaofeng Huang, et al.
Pageof 3